Comparison

CDK/HDAC-IN-3 European Partner

Item no. TMO-T78906-25mg
Manufacturer TargetMol
CASRN 2944087-54-9
Amount 25 mg
Quantity options 100 mg 100 mg 25 mg 25 mg 50 mg 50 mg
Category
Type Peptides
Specific against other
Smiles N(C(=O)C1=C(Cl)C=CC=C1Cl)C=2C(C(NC3=CC=C(C(NC4=C(N)C=CC=C4)=O)C=C3)=O)=NNC2
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Shipping Condition Cool pack
Available
Manufacturer - Targets
CDK|||HDAC
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
509, 34
Description
CDK/HDAC-IN-3 is an orally active dual inhibitor of HDACs and CDKs, offering potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2, and HDAC3, with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28 nM, and 82.87 nM, respectively, and is applicable in the treatment of acute myeloid leukemia (AML) [1].
Pathways
Cell Cycle/Checkpoint|||Chromatin/Epigenetic|||DNA Damage/DNA Repair

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close